PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers’ pharmacokinetics.
Sachpekidis C et al. Eur J Nucl Med Mol Imaging. 2014 Feb 22. [Epub ahead of print].
Inter-laboratory comparison of Beta-2 microglobulin and albumin methods: impact of assay variation on multiple myeloma staging.
Fedele PL et al. Pathology. 2014 Feb;46 Suppl 1:S51. doi: 10.1097/PAT.0000000000000061.
New diagnostic strategies for assessment of amyloidosis and myeloma.
Mollee P. Pathology. 2014 Feb;46 Suppl 1:S32. doi: 10.1097/01.PAT.0000443473.89668.b2.
Monitoring M-proteins in Patients with Multiple Myeloma using Heavy Chain Variable Region Clonotypic Peptides and LC-MS/MS.
Barnidge DR et al. J Proteome Res. 2014 Feb 19. [Epub ahead of print].
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.
Merz M et al. Leukemia. 2014 Feb 18. doi: 10.1038/leu.2014.75. [Epub ahead of print].
Ferritin as prognostic marker in multiple myeloma in patient undergoing autologous transplantation.
Strasser-Weippl K et al. Leuk Lymphoma. 2014 Feb 11. [Epub ahead of print].
The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma.
Zhang Y et al. Mol Cancer. 2014 Feb 5;13:25. doi: 10.1186/1476-4598-13-25.
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.
Gambella M et al. Haematologica. 2014 Feb;99(2):e14-6. doi: 10.3324/haematol.2013.090142.
Serum-free light-chain assay: clinical utility and limitations.
Bhole MV et al. Ann Clin Biochem. 2014 Jan 31. [Epub ahead of print].
Staging and prognostication of multiple myeloma.
Fonseca R et al. Expert Rev Hematol. 2014 Feb;7(1):21-31. doi: 10.1586/17474086.2014.882224.
New body scans help detect spread of myeloma.
Kmietowicz Z. BMJ. 2014 Jan 29;348:g1170. doi: 10.1136/bmj.g1170.
Unsustained complete response of less than 24 months after autologous stem cell transplantation predicts aggressive myeloma with short survival.
Chim CS et al. Hematol Oncol. 2014 Jan 29. doi: 10.1002/hon.2131. [Epub ahead of print].
Using Mass Spectrometry to Monitor Monoclonal Immunoglobulins in Patients with a Monoclonal Gammopathy.
Barnidge DR et al. J Proteome Res. 2014 Feb 11. [Epub ahead of print].
Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.
Jimenez-Zepeda VH et al. Leuk Lymphoma. 2014 Feb 24. [Epub ahead of print].
Survival analysis with functional covariates for partial follow-up studies.
Fang HB et al. Stat Methods Med Res. 2014 Feb 24. [Epub ahead of print].